Understanding Pharmaceutical Product Compositions and Packaging
Why Accurate Label Reading Matters
A pharmaceutical label is a legally mandated declaration of what a medicine contains, how it is to be stored, and who manufactured it. Under the Drugs and Cosmetics Act, 1940 and the Rules thereunder, every licensed pharmaceutical product sold in India must carry specific mandatory declarations on its primary and secondary packaging.
For distributors, healthcare professionals, and informed patients, knowing how to read these declarations accurately avoids confusion between similar brand names, prevents errors when comparing products, and enables meaningful questions when consulting a prescriber or pharmacist.
This guide focuses on the technical aspects of reading labels — it does not constitute medical advice. For any clinical decisions regarding medicine selection, dosage, or treatment, consult a qualified medical practitioner.
Reading Pharmaceutical Compositions and Strengths
Pharmaceutical labeling follows strict statutory guidelines. A product label must accurately reflect active pharmaceutical ingredients (APIs), their specific salt or ester forms, and their quantified strengths per dosage unit.
Active Pharmaceutical Ingredients vs. Excipients
The composition section of a label lists Active Pharmaceutical Ingredients (APIs) — the therapeutic substances responsible for the intended clinical effect. Excipients (binders, fillers, preservatives, flavours) are generally not listed on the front label panel but may appear in patient information leaflets or as declarations when specific excipients require mandatory disclosure, such as sucrose for diabetics or certain preservatives in eye preparations.
Base vs. Salt Form
Many active substances are formulated as salts to enhance stability, solubility, or bioavailability. For example, a formulation may specify 'Calcium Citrate Malate' rather than simply 'Calcium', or 'Drotaverine Hydrochloride' rather than 'Drotaverine'. The specific salt form is a critical technical characteristic. Two products listing the same generic active substance in different salt forms are pharmacologically and sometimes clinically distinct — their bioavailability profiles may differ.
When comparing products across catalogues or evaluating substitutions, always check the complete salt designation, not just the base generic name.
Units of Measurement
Strengths are quantified in standardized units. Milligrams (mg) and micrograms (mcg or µg) are the most common. One milligram equals 1,000 micrograms — a difference of three orders of magnitude. Confusing the two units for high-potency micronutrients such as Calcitriol (typically in mcg), Vitamin B12 (Cyanocobalamin or Methylcobalamin, in mcg), or Folic Acid is a source of frequent practical error.
International Units (IU) are used for vitamins where biological activity is the standard measure rather than mass: Vitamin D3 (Cholecalciferol) is commonly expressed in IU. Percentage weight-by-volume (% w/v) applies to dissolved substances in liquid formulations. Percentage weight-by-weight (% w/w) applies to active concentrations in topical ointments and gels.
Dose-Volume Bases for Liquids
For oral liquids — syrups, suspensions, and drops — compositions are expressed relative to a specified dose-volume. The most common expressions are 'Each 5 ml contains...' for adult or paediatric syrups and 'Each 1 ml contains...' for concentrated paediatric drops. This dose-volume base must be identified before any dosage calculation is made.
A common source of confusion arises when a syrup states 'Each 5 ml contains 200 mg' and a drop formulation states 'Each ml contains 100 mg'. The concentrations per ml are different. Always confirm the stated dose-volume before interpreting composition strength.
Controlled or Modified-Release Designations
Suffixes such as SR (Sustained Release), CR (Controlled Release), ER (Extended Release), XL (Extended Release), and DR (Delayed Release) indicate that the dosage form is engineered to deliver the active ingredient over an extended period or at a specific site in the gastrointestinal tract. Modified-release formulations must not be substituted for immediate-release equivalents without clinical guidance, as their release kinetics and safety profiles can differ substantially.
Combination Products and the '+' Convention
Many pharmaceutical products are fixed-dose combinations (FDCs) containing two or more active ingredients in a single dosage unit. On Indian product labels and catalogues, combinations are typically presented with a '+' separator between each active ingredient and its respective strength.
For example, 'Paracetamol 325 mg + Tramadol 37.5 mg' indicates a tablet containing both APIs at those individual strengths. Each component's strength is listed independently. Reading FDC compositions correctly helps distinguish between products that share common ingredients but differ in the identity or strength of the co-ingredient.
In some combinations, the same active appears in two different forms — for example, Magnesium as both Magnesium Oxide and Magnesium Hydroxide in the same product. Each form has a distinct entry in the composition listing.
Pharmaceutical Packaging Standards and Barrier Materials
Packaging in pharmaceuticals is an integral component of stability assurance, not merely a commercial consideration. Different dosage forms and active ingredients require specialized primary packaging materials to maintain product integrity over the declared shelf life under specified storage conditions.
Alu-Alu Blister Packaging
Cold-formed Alu-Alu (aluminium foil laminate on both the forming and lidding side) provides near-total barrier protection against moisture, oxygen, light, and gases. It is the preferred packaging for hygroscopic tablets, moisture-sensitive vitamins, thermolabile compounds, and antibiotic formulations where exposure to ambient humidity during the supply chain could compromise potency or stability.
Alu-Alu-packaged products are visually identifiable by their opaque, embossed metallic appearance on both sides of the blister strip.
Blister Packaging (PVC / PVDC / Alu Lidding)
Standard blister packaging uses a thermoformed PVC (Polyvinyl Chloride) or PVC-PVDC base film sealed against an aluminium foil lidding. PVC blister allows visual inspection of the dosage form, which is useful for tablets and capsules where colour uniformity or physical integrity verification is helpful.
Where enhanced moisture barrier is needed beyond basic PVC, PVDC (Polyvinylidene Chloride) coatings are applied to the forming film. PVDC provides better moisture barrier properties than plain PVC while retaining visual clarity.
Liquid Containers — Amber PET and Glass Bottles
Syrups, suspensions, and drops sensitive to photodegradation are packaged in amber-tinted bottles. High-grade PET (Polyethylene Terephthalate) bottles provide shatter resistance during transit while offering light protection. Calibrated measuring cups, spoons, or droppers allow accurate dispensing per the prescribed dose-volume.
Liquid products with stability requirements beyond what plastic offers — certain injectables and specialized formulations — use Type I borosilicate glass containers, which have minimal extractables and are chemically inert.
Injectable Formulations — Ampoules and Vials
Parenteral formulations must maintain sterile integrity from manufacture through to point of administration. Glass ampoules with scored necks for clean-break opening are used for single-dose injectables. Vials are closed with bromobutyl or chlorobutyl rubber closures and secured with flip-off aluminium seals.
Lyophilised (freeze-dried) injectables requiring reconstitution before use are supplied in vials with a separate diluent ampoule or vial. The condition of the rubber stopper and aluminium seal integrity should be visually checked before any injectable product is stocked or administered.
Sachet and Unit-Dose Packaging
Powders for oral administration — effervescent formulations, nutritional supplements, and some antibiotic granules — are commonly packed in individual foil sachets. Each sachet typically contains a single dose and is heat-sealed to provide moisture and tamper evidence. Sachet labelling must state the reconstitution instructions and the resulting concentration per dose.
Storage Instructions and Their Significance
Storage instructions on pharmaceutical labels are not advisory — they are stability commitments from the manufacturer. 'Store below 25°C' means the product's declared shelf life and stability specifications were validated at that temperature. Exposure to higher temperatures accelerates degradation of thermolabile actives.
Common storage declarations include: 'Store in a cool, dry place' (generally below 25°C, relative humidity below 60%); 'Store between 2°C and 8°C' (refrigerator storage for cold-chain products); 'Protect from light' (applicable to photosensitive APIs); and 'Do not freeze' (relevant for liquid preparations where freezing can cause phase separation or physical degradation).
Distributors are responsible under their wholesale drug licence for maintaining appropriate storage conditions in their premises. Deviation from storage requirements can compromise product efficacy and constitutes a regulatory non-compliance.
Expiry Dates and Batch Traceability
Every pharmaceutical product must carry a batch number and an expiry date (or manufacturing date plus shelf life period). The batch number links to batch manufacturing records, quality control test results, and certificates of analysis held by the manufacturer — enabling traceability in the event of a quality complaint or recall.
The expiry date indicates the end of the declared shelf life when the product is stored under specified conditions with its original packaging intact. Distributors and retailers are legally prohibited from selling medicines past their expiry date under the Drugs and Cosmetics Act.
When examining new stock, verify that batch numbers, manufacturing dates, and expiry dates are clearly legible and consistent across all units in a supplied lot.
Explore Related Resources at My Best Remedies
Browse our therapeutic divisions, check verified formulation details, or discuss franchise opportunities with our team.
Questions Addressed in This Guide
Why do some tablets use Alu-Alu while others use standard blister packaging?
Alu-Alu provides superior moisture and light barrier protection for sensitive or hygroscopic molecules. Standard blister packaging (PVC or PVC-PVDC with aluminium lidding) is suitable for stable formulations and offers the advantage of visual product inspection. The choice depends on the active ingredient's stability profile and the regulatory commitments made during product registration.
What does 'Each 5 ml contains' on syrup bottles mean?
It defines the concentration of active ingredients per standard 5 ml teaspoon dose — the prescribed dose-volume base. All strength values listed apply to that 5 ml volume. This is the reference for calculating how much active ingredient a patient receives per dose and for making valid comparisons between products.
How do I tell if a product is controlled-release or immediate-release?
Look for suffixes after the brand name or in the dosage form description: SR (Sustained Release), CR (Controlled Release), ER (Extended Release), XL (Extended Release), LA (Long-Acting), or DR (Delayed Release). If no such suffix is present, the product is generally an immediate-release formulation. These designations are also reflected in the product's drug registration documents.
Can I substitute a salt form of an active ingredient with a different salt of the same drug?
Salt substitution is a clinical decision that should not be made without the prescriber's guidance. Different salt forms can have different bioavailability, onset of action, and adverse effect profiles. Pharmacists and distributors should not substitute salt forms without explicit prescriber authorisation.
What should I check on injectable packaging before stocking?
Verify that: the rubber stopper is intact and undamaged; the aluminium flip-off seal is intact and has not been disturbed; the glass ampoule or vial is free from cracks, particulates, or colour changes; the product is within its declared expiry date; and the batch number, manufacturing date, and expiry date are clearly legible on both the primary container and the outer carton.